根治性切除术后结直肠癌患者的胸部复发:发生率、危险因素及术后监测中胸部CT的价值
本回顾性研究纳入648例根治性手术的结直肠癌患者,中位随访57个月,胸部复发率8.0%(52/648),其中仅5例(0.8%)通过胸部CT诊断。结论认为常规胸部CT监测价值有限,尤其对于0期和I期患者,因仅通过胸部CT发现的复发罕见。
要点
- 根治性切除术后结直肠癌胸部复发率8.0%,仅0.8%通过胸部CT诊断。
- 0期和I期结直肠癌患者未发生胸部复发。
- 术后监测使用胸部CT的价值可能有限,尤其对于0期或I期患者。
核心结论
- 在根治性切除的结直肠癌患者中,常规胸部CT监测价值可能有限,尤其对于0期或I期患者,因为仅通过胸部CT发现的复发罕见。
研究设计与样本
- 回顾性研究,纳入648例于2010年1月至2012年12月接受根治性手术的结直肠癌患者(男:女=393:255,平均年龄66.2岁),分析随访期间复发情况,采用Kaplan-Meier分析及log-rank检验评估无复发生存,Cox回归分析危险因素。
诊断标准与关键数值
- 中位随访57个月,胸部复发率8.0%(52/648),中位无复发生存期19.5个月。
- 52例胸部复发患者中,18例(2.7%)为孤立性胸部复发,仅5例(0.8%)通过胸部CT诊断。
- 总体胸部复发的危险因素包括年龄(OR=1.78,p=0.045)、切缘阳性(OR=19.691,p=0.004)、静脉侵犯(OR=2.993,p=0.001)、病理N分期阳性(OR=2.502,p=0.005)及腹部复发(OR=31.137,p<0.001)。
- 孤立性胸部复发的唯一预测因素为术后随访期间血清癌胚抗原水平≥5 ng/mL(OR=9.112,p<0.001)。
- 0期和I期结直肠癌患者未发生胸部复发。
临床应用与阅片要点
- 作者认为,在根治性切除的结直肠癌患者中,常规胸部CT监测价值可能有限,尤其对于0期或I期患者。
- 术后随访期间血清癌胚抗原水平≥5 ng/mL与孤立性胸部复发相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the incidence of thoracic recurrence and the diagnostic value of chest CT for postoperative surveillance in curatively-resected colorectal cancer (CRC) patients.
METHODS: This retrospective study consisted of 648 CRC patients (M:F, 393:255; mean age, 66.2 years) treated with curative surgery between January 2010 and December 2012. The presence of CRC recurrence over follow-ups was analysed and recurrence-free survival and risk factors of recurrence were assessed using Kaplan-Meier analysis with log-rank test and Cox-regression analysis, respectively.
RESULTS: Over a median follow-up of 57 months, thoracic recurrence occurred in 8.0% (52/648) of patients with a median recurrence-free survival rate of 19.5 months. Among the 52 patients with thoracic recurrence, 18 (2.7%) had isolated thoracic recurrence, and only five (0.8%) were diagnosed through chest CT. Risk factors of overall thoracic recurrence included age, positive resection margin, presence of venous invasion, positive pathologic N-class, and presence of abdominal recurrence (odds ratio [OR] = 1.78, 19.691, 2.993, 2.502, and 31.137; p = 0.045, 0.004, 0.001, 0.005, and p < 0.001, respectively). As for isolated thoracic recurrence, serum carcinoembryonic antigen level ≥ 5 ng/mL during postoperative follow-up (OR = 9.112; p < 0.001) was demonstrated to be the only predictive factor. There were no thoracic recurrences in patients with CRC stages 0 and I.
CONCLUSION: In patients with curatively-resected CRCs, routine surveillance using chest CT may be of limited value, particularly in those with CRC stages 0 or I, as recurrence only detectable through chest CT was shown to be rare.
KEY POINTS: • Postoperative thoracic recurrence only detectable through chest CT was shown to be rare. • There were no thoracic recurrences in colorectal cancers stage 0 and I. • Postoperative surveillance chest CT is of limited value in patients with curatively resected colorectal cancers.
引用
- Lee JH, Park CM, Joo I, et al. Thoracic recurrence in patients with curatively-resected colorectal cancer: incidence, risk factors, and value of chest CT as a postoperative surveillance tool. Eur Radiol. 2018. PMID: 30350166. doi:10.1007/s00330-018-5712-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。